Hematology - European Medical Journal

Continue

Hematology

Filter
20 Aug 2022

Increasing Awareness in Beta-Thalassemia

This series of webinars focusses on Beta-Thalassemia. These are scientific presentations and discussions for the purpose of scientific exchange.
16 Aug 2022

Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk MDS Treatment

This satellite symposium discusses current key topics in higher-risk MDS, including treatment outcome measures
21 Jul 2022

New Treatment Options in Paediatric Thalassemia

The third of our six-part series focuses on new treatment options in paediatric thalassemia with expert Dr Immacolata Tartaglione, paediatrician at University of Campania Luigi Vanvitelli in Napoli, Italy.
31 May 2022

Novel targets for therapy in TD β-Thalassaemia

The second of our six-part series focusing on increasing awareness of β-thalassaemia features Khaled Musallam, Clinical Professor at…
Biosimilars CME webinar
25 May 2022

CME-Accredited Webinar on Biosimilars within Haematology & Oncology

This presidential debate-style discussion explores the topic of biosimilars within haematology and oncology.
Acute Myeloid Leukemia
13 May 2022

Jazz-Sponsored Symposium - High-risk AML* in 2022: what is the go-to strategy?

*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
28 Apr 2022

Clinical Challenges and Limitations in β-Thalassaemia Treatment and Their Impact on Patient Outcomes

Cappellini shares her expert insights into β-thalassaemia with our chair, internationally renowned surgeon Jonathan Sackier. With a focus…
ESMO 2021 AML symposium
30 Sep 2021

ESMO 2021 Jazz Pharmaceuticals AML symposium

Insight beyond Phase 3: Does real-world evidence impact how we treat high-risk AML…